V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Prelude Therapeutics, Inc. Debut trading.

26.09.2020

In their debut trading on Friday, September 25 Prelude Therapeutics showed a 37.89 % raise and closed at $26.20 per share. Shortly before the company placed its shares in an IPO priced $19 per share.